substance information of the executive summary as provided in section 1 of the registration statement together with the subscription forms. Clause 10 A securities underwriter shall not disseminate information

with the subscription forms under the first paragraph. 11 In case of offering for sale of shares, the securities underwriter shall distribute the same substance information of the executive summary as

) Director & Senior Vice President Nawarat Patanakarn Public Company Limited NAWARAT PATANAKARN PUBLIC COMPANY LIMITED SUMMARY OF FINANCIAL POSITION AND PERFORMANCE FOR THE PERIOD OF ONE YEAR ENDED DECEMBER 31

reclassification of the revenues, cost of sales, cost of rental and services, and SG&A. However, there is no impact on the net profit as follows: Table 1: Financial Summary for the three-month period of the year

Discussion and Analysis as follows : FINANCIAL SUMMARY 31.12.17 31.12.18 31.03.19 FINANCIAL POSITION (MILLION BAHT) Current Assets 1,119 1,154 1,196 Total Assets 1,242 1,268 1,309 Current Liabilities 784 808

control such as utilities expenses and marketing expenses. Summary of Financial Statement of Positions 31 Dec 2018 31 Mar 2019 Change MB. % MB. % MB. % Cash and cash equivalents 21.4 0.9% 23.4 1.0% 2.0 9.3

Limited (“the Company”) would like to submit this Management Discussion and Analysis for the three-month period ended 31 March 2019 with details as follows: Summary overview In the first quarter of 2019

& Senior Vice President Nawarat Patanakarn Public Company Limited (Translation) NAWARAT PATANAKARN PUBLIC COMPANY LIMITED SUMMARY OF FINANCIAL POSITION AND PERFORMANCE FOR THE PERIOD OF ONE THREE MONTHS

Company has net profit of Baht 191 million in Q1/2018. Financial Performance Summary – by business Revenues by business THB’000 Consolidated Q1/2019 Q1/2018 ∆% Distributor of medical devices and equipment

incurred in marketing expenses and employee expense from coffee shop business. Summary of Financial Statement of Positions 30-Jun-19 31-Dec-18 Change %Change Assets Cash and Cash Equivalents 232.7 21.4 211.3